Search results
Showing 1681 to 1695 of 8213 results
Awaiting development Reference number: GID-QS10036 Expected publication date: TBC
Awaiting development Reference number: GID-QS10038 Expected publication date: TBC
Awaiting development Reference number: GID-QS10085 Expected publication date: TBC
Awaiting development Reference number: GID-QS10086 Expected publication date: TBC
Awaiting development Reference number: GID-QS10088 Expected publication date: TBC
Awaiting development Reference number: GID-QS10091 Expected publication date: TBC
Awaiting development Reference number: GID-QS10093 Expected publication date: TBC
Shared decision-making: practical guidance for health and social care professionals
Awaiting development Reference number: GID-QS10097 Expected publication date: TBC
Awaiting development Reference number: GID-QS10100 Expected publication date: TBC
Awaiting development Reference number: GID-QS10101 Expected publication date: TBC
In development Reference number: GID-TA10248 Expected publication date: TBC
Talacotuzumab for untreated acute myeloid leukaemia [ID1262]
In development Reference number: GID-TA10249 Expected publication date: TBC
Avelumab for untreated PD-L1 positive recurrent or metastatic non-small-cell lung cancer [ID1261]
In development Reference number: GID-TA10250 Expected publication date: TBC
Doxorubicin nanoparticles for previously treated advanced hepatocellular carcinoma [ID1314]
In development Reference number: GID-TA10251 Expected publication date: TBC
Sparsentan for treating focal segmental glomerulosclerosis in people 8 years and over [ID3955]
Awaiting development Reference number: GID-TA10867 Expected publication date: TBC